Data / Drug companies / Penn Pharmaceutical Services Limited
Penn Pharmaceutical Services Limited: 24 products in the FDA NDC directory, labeler code 63069
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Penn Pharmaceutical Services Limited (labeler code 63069) lists 24 products in the FDA National Drug Code Directory. By type: 24 drugs for further processing. Its main marketing category is drugs for further processing. The newest product started marketing on March 22, 2024.
The request: Watch Penn Pharmaceutical Services Limited (FDA labeler code 63069): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 63069
- Products in commercial distribution
- 24
- Packages
- 29
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- July 25, 2011
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Drugs for further processing | 24 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Drugs for further processing | 24 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 12 | 50% |
| Capsule | 5 | 20.8% |
| Tablet | 4 | 16.7% |
| Liquid | 2 | 8.3% |
| Solution | 1 | 4.2% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Macitentan and tadalafil | 63069-103 | Tablet, film coated | Drugs for further processing | March 22, 2024 |
| Macitentan and tadalafil | 63069-102 | Tablet, film coated | Drugs for further processing | March 22, 2024 |
| Etrasimod | 63069-052 | Tablet, film coated | Drugs for further processing | November 1, 2023 |
| Futibatinib | 63069-101 | Tablet | Drugs for further processing | February 3, 2023 |
| Fenfluramine hydrochloride | 63069-525 | Solution | Drugs for further processing | July 15, 2020 |
| Osilodrostat phosphate | 63069-109 | Tablet, film coated | Drugs for further processing | March 31, 2020 |
| Osilodrostat phosphate | 63069-108 | Tablet, film coated | Drugs for further processing | March 31, 2020 |
| Osilodrostat phosphate | 63069-107 | Tablet, film coated | Drugs for further processing | March 31, 2020 |
| Larotrectinib | 63069-392 | Liquid | Drugs for further processing | November 26, 2018 |
| Larotrectinib | 63069-391 | Capsule | Drugs for further processing | November 26, 2018 |
| Larotrectinib | 63069-390 | Capsule | Drugs for further processing | November 26, 2018 |
| Sarecycline hydrochloride | 63069-247 | Tablet, film coated | Drugs for further processing | October 1, 2018 |
| Sarecycline hydrochloride | 63069-246 | Tablet, film coated | Drugs for further processing | October 1, 2018 |
| Sarecycline hydrochloride | 63069-245 | Tablet, film coated | Drugs for further processing | October 1, 2018 |
| Nitisinone | 63069-075 | Tablet | Drugs for further processing | July 26, 2017 |
| Nitisinone | 63069-072 | Tablet | Drugs for further processing | July 26, 2017 |
| Nitisinone | 63069-071 | Tablet | Drugs for further processing | July 26, 2017 |
| Glycerol phenylbutyrate | 63069-106 | Liquid | Drugs for further processing | February 28, 2013 |
| Ospemifene | 63069-601 | Tablet, film coated | Drugs for further processing | February 26, 2013 |
| Pomalidomide | 63069-404 | Capsule | Drugs for further processing | February 8, 2013 |
| Pomalidomide | 63069-403 | Capsule | Drugs for further processing | February 8, 2013 |
| Pomalidomide | 63069-402 | Capsule | Drugs for further processing | February 8, 2013 |
| Vandetanib | 63069-784 | Tablet, film coated | Drugs for further processing | July 25, 2011 |
| Vandetanib | 63069-782 | Tablet, film coated | Drugs for further processing | July 25, 2011 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.